That'd really depend on the variance of the cohort. Even if an individual patient is performing better, it's unlikely all of them are. Also, the trials are geographically displaced...
HHL Price at posting:
$2.43 Sentiment: None Disclosure: Not Held
SRX Price at posting:
$39.13 Sentiment: Hold Disclosure: Held